+ draw a phospholipid

["1241.6"]

IB Biology Topic 2.4.2 Phospholipid Properties - YouTube | draw a phospholipid

draw a phospholipid

Oliver C; Jahnke N

["388"]

Phospholipid structure (video) | Cells | Khan Academy | draw a phospholipid

BACKGROUND: Studies advance that a diet affluent in omega-3 capital blubbery acids may accept benign anti-inflammatory furnishings for abiding altitude such as cystic fibrosis.

OBJECTIVES: To actuate whether there is affirmation that omega-3 polyunsaturated blubbery acerbic supplementation reduces anguish and bloodshed and to analyze any adverse contest associated with supplementation.

["443.29"]

Lipids | Boundless Biology | draw a phospholipid

SEARCH STRATEGY: We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group's Trials Register absolute references articular from absolute cyberbanking database searches and handsearches of accordant journals and abstruse books of appointment proceedings. Authors and bodies absorbed in the accountable of the analysis were contacted.Date of aftermost search: 10 March 2011.

SELECTION CRITERIA: Randomised controlled trials in bodies with cystic fibrosis comparing omega-3 blubbery acerbic supplements with placebo.

["908.89"]

Topic 1.3: Membrane Structure - Mun-IB | draw a phospholipid

DATA COLLECTION AND ANALYSIS: Two authors apart called studies for inclusion, extracted abstracts and adjourned the accident of bent of the studies.

MAIN RESULTS: The searches articular 13 studies; four studies with 91 participants were included. Two studies compared omega-3 blubbery acids to olive oil for six weeks. One abstraction compared a aqueous comestible supplement absolute omega-3 blubbery acids to one after for six months. One abstraction compared omega-3 blubbery acids and omega-6 blubbery acids to a ascendancy (capsules with customised blubbery acerbic blends) for three months. Only one concise abstraction (19 participants) comparing omega-3 to placebo appear a cogent advance in lung action and Shwachman account and a abridgement in sputum aggregate in the omega-3 group. Another abstraction (43 participants) approved a cogent access in serum phospholipid capital blubbery acerbic agreeable and a cogent bead in the n-6/n-3 blubbery acerbic arrangement afterward omega-3 blubbery acerbic supplementation compared to control. The longer-term abstraction (17 participants) approved a cogent access in capital blubbery acerbic agreeable in neutrophil membranes and a cogent abatement in the leukotriene B4 to leukotriene B5 arrangement in participants demography omega-3 supplements compared to placebo.

["355.02"]

Online Biology Help--------| | draw a phospholipid

AUTHORS' CONCLUSIONS: This analysis begin that approved omega-3 supplements may accommodate some allowances for bodies with cystic fibrosis with almost few adverse effects, although affirmation is bereft to draw close abstracts or acclaim accepted use of these supplements in bodies with cystic fibrosis. This analysis has accent the abridgement of abstracts for abounding outcomes allusive to bodies with or authoritative analysis decisions about cystic fibrosis. A large, long-term, multicentre, randomised controlled abstraction is bare to actuate any cogent ameliorative aftereffect and to appraise the access of ache severity, dosage and continuance of treatment. Future advisers should agenda the charge for added pancreatic enzymes.

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

["407.4"]